GoodRx (Nasdaq: GDRX), the leading prescription savings platform in the U.S., today announced that Christopher A. McGinnis has been appointed as Chief Financial Officer, effective February 4, 2025.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback